Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Solomon

Showing results (841-850 of 1,173) with videos related to

Pageof 118
Sort By:
Rheumatology (Oxford, England)|June 18, 2021
Adverse effects related to methotrexate polyglutamate levels: adjudicated results from the cardiovascular inflammation reduction trialChang Xu, Jacob Selhub, Paul Jacques, et al.
The Journal of Clinical Endocrinology and Metabolism|January 3, 2020
Delayed Denosumab Injections and Bone Mineral Density Response: An Electronic Health Record-based StudyHouchen Lyu, Sizheng S Zhao, Kazuki Yoshida, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2021
Validation of a Bioassay for Predicting Response to Tumor Necrosis Factor Inhibitors in Rheumatoid ArthritisChing-Huang Ho, Andrea A Silva, Jon T Giles, et al.
Seminars in Arthritis and Rheumatism|November 10, 2021
Risk of venous thromboembolism associated with methotrexate versus hydroxychloroquine for rheumatoid arthritis: A propensity score-matched cohort studyMengdong He, Ajinkya Pawar, Rishi J Desai, et al.
The Journal of Clinical Endocrinology and Metabolism|July 3, 2019
Comparison of Teriparatide and Denosumab in Patients Switching From Long-Term Bisphosphonate UseHouchen Lyu, Sizheng S Zhao, Kazuki Yoshida, et al.
Journal of the American Heart Association|February 28, 2024
Biomarkers of Cardiovascular Risk in Patients With Rheumatoid Arthritis: Results From the TARGET TrialDaniel H Solomon, Olga Demler, Pamela M Rist, et al.
Nano Letters|August 9, 2008
Autophobicity-driven surface segregation and patterning of core-shell microgel nanoparticlesBin Wei, Paul A Gurr, Arif O Gozen, et al.
Arthritis and Rheumatism|March 30, 2011
End-stage renal disease due to lupus nephritis among children in the US, 1995-2006Linda T Hiraki, Bing Lu, Steven R Alexander, et al.
Arthritis Research & Therapy|June 10, 2011
Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational studyYvonne C Lee, Jing Cui, Bing Lu, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 25, 2006
A randomized controlled trial of mailed osteoporosis education to older adultsD H Solomon, J S Finkelstein, J M Polinski, et al.
Pageof 118

Showing results (841-850 of 1,173) with videos related to

Sort By:
Pageof 118
Rheumatology (Oxford, England)|June 18, 2021
Adverse effects related to methotrexate polyglutamate levels: adjudicated results from the cardiovascular inflammation reduction trialChang Xu, Jacob Selhub, Paul Jacques, et al.
The Journal of Clinical Endocrinology and Metabolism|January 3, 2020
Delayed Denosumab Injections and Bone Mineral Density Response: An Electronic Health Record-based StudyHouchen Lyu, Sizheng S Zhao, Kazuki Yoshida, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2021
Validation of a Bioassay for Predicting Response to Tumor Necrosis Factor Inhibitors in Rheumatoid ArthritisChing-Huang Ho, Andrea A Silva, Jon T Giles, et al.
Seminars in Arthritis and Rheumatism|November 10, 2021
Risk of venous thromboembolism associated with methotrexate versus hydroxychloroquine for rheumatoid arthritis: A propensity score-matched cohort studyMengdong He, Ajinkya Pawar, Rishi J Desai, et al.
The Journal of Clinical Endocrinology and Metabolism|July 3, 2019
Comparison of Teriparatide and Denosumab in Patients Switching From Long-Term Bisphosphonate UseHouchen Lyu, Sizheng S Zhao, Kazuki Yoshida, et al.
Journal of the American Heart Association|February 28, 2024
Biomarkers of Cardiovascular Risk in Patients With Rheumatoid Arthritis: Results From the TARGET TrialDaniel H Solomon, Olga Demler, Pamela M Rist, et al.
Nano Letters|August 9, 2008
Autophobicity-driven surface segregation and patterning of core-shell microgel nanoparticlesBin Wei, Paul A Gurr, Arif O Gozen, et al.
Arthritis and Rheumatism|March 30, 2011
End-stage renal disease due to lupus nephritis among children in the US, 1995-2006Linda T Hiraki, Bing Lu, Steven R Alexander, et al.
Arthritis Research & Therapy|June 10, 2011
Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational studyYvonne C Lee, Jing Cui, Bing Lu, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 25, 2006
A randomized controlled trial of mailed osteoporosis education to older adultsD H Solomon, J S Finkelstein, J M Polinski, et al.
Pageof 118